skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway

Journal Article · · Journal of Immunotoxicology
 [1];  [2];  [3];  [4];  [2]
  1. Univ. of Colorado Denver, Aurora CO (United States). Anschutz Medical Campus
  2. Univ. of Colorado Denver, Aurora CO (United States). Anschutz Medical Campus
  3. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States). Chemical Sciences Division
  4. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States). Biosciences Biotechnology Division

Exposure to small amounts of beryllium (Be) can result in beryllium sensitization and progression to Chronic Beryllium Disease (CBD). In CBD, beryllium is presented to Be-responsive T-cells by professional antigen-presenting cells (APC). This presentation drives T-cell proliferation and pro-inflammatory cytokine (IL-2, TNFα, and IFNγ) production and leads to granuloma formation. The mechanism by which beryllium enters an APC and is processed to become part of the beryllium antigen complex has not yet been elucidated. Developing techniques for beryllium detection with enough sensitivity has presented a barrier to further investigation. The objective of this study was to demonstrate that Accelerator Mass Spectrometry (AMS) is sensitive enough to quantify the amount of beryllium presented by APC to stimulate Be-responsive T-cells. To achieve this goal, APC - which may or may not stimulate Be-responsive T-cells - were cultured with Be-ferritin. Then, by utilizing AMS, the amount of beryllium processed for presentation was determined. Further, IFNγ intracellular cytokine assays were performed to demonstrate that Be-ferritin (at levels used in the experiments) could stimulate Be-responsive T-cells when presented by an APC of the correct HLA type (HLA-DP0201). The results indicated that Be-responsive T-cells expressed IFNγ only when APC with the correct HLA type were able to process Be for presentation. Utilizing AMS, it was determined that APC with HLA-DP0201 had membrane fractions containing 0.17-0.59 ng Be and APC with HLA-DP0401 had membrane fractions bearing 0.40-0.45 ng Be. However, HLA-DP0401 APC had 20-times more Be associated with the whole cells (57.68-61.12 ng) than HLA-DP0201 APC (0.90-3.49 ng). As these findings demonstrate, AMS detection of picogram levels of Be processed by APC is possible. Further, regardless of form, Be requires processing by APC to successfully stimulate Be-responsive T-cells to generate IFNγ.

Research Organization:
Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-07NA27344
OSTI ID:
1282176
Alternate ID(s):
OSTI ID: 1377773
Report Number(s):
LLNL-JRNL-653850
Journal Information:
Journal of Immunotoxicology, Vol. 12, Issue 2; ISSN 1547-691X
Publisher:
Taylor & FrancisCopyright Statement
Country of Publication:
United States
Language:
English

References (18)

Identification of HLA-DRPheβ47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGluβ69 journal August 2005
Chronic Beryllium Disease: T Cell Recognition of a Metal Presented by HLA-DP journal July 2001
Recombinant HLA-DP2 Binds Beryllium and Tolerizes Beryllium-Specific Pathogenic CD4 + T Cells journal September 2006
Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. journal April 1990
Measurement of Beryllium in Biological Samples by Accelerator Mass Spectrometry:  Applications for Studying Chronic Beryllium Disease journal December 2004
A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors journal December 2004
Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response journal October 2005
Components of the Ligand for a Ni++ Reactive Human T Cell Clone journal March 2003
Proliferative Response of Bronchoalveolar Lymphocytes to Beryllium: A Test for Chronic Beryllium Disease journal May 1988
Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease journal October 2000
Industries in the United States with Airborne Beryllium Exposure and Estimates of the Number of Current Workers Potentially Exposed journal October 2004
Graphite furnace atomic absorption spectrometry as a routine method for the quantification of beryllium in blood and serum journal July 2008
Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Specific Helper T Cells journal April 1989
Beryllium Sensitization Progresses to Chronic Beryllium Disease: A Longitudinal Study of Disease Risk journal January 2005
Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease journal November 2002
Beryllium exposure and chronic beryllium disease journal February 2004
Beryllium-Induced Tumor Necrosis Factor-α Production by CD4 + T Cells Is Mediated by HLA-DP journal July 2004
Frequency of beryllium-specific, T1-type cytokine-expressing CD4 T cells in patients with beryllium-induced disease journal May 2005